After salivating at the Alibaba IPO, hedge fund managers lucky enough to buy in early are indeed getting a nice kick to their returns.» Read More
Wall Street is spending more on the midterms than ever before—particularly in support of the GOP—but it's not from whom you might think.
Founder and CEO, Third Point LLC
Third Point has taken a "significant" position in eBay, a source told CNBC.
Starboard Value sent a letter to Yahoo on Friday listing several opportunities to increase shareholder value and recommending that it merge with AOL.
A recent move by CalPERS was seen as a victory for critics of hedge funds' high fees and low transparency and liquidity.
He bashed rival funds such as Elliott Management, which has invested in Argentine bonds and held out for full payment, calling their behavior immoral.
"I think this is bait for an activist," Ritholtz Wealth Management's Josh Brown says of Yahoo's stock after Alibaba's IPO.
Investors want more of activist hedge fund manager Dan Loeb, and they're putting up lots of cash to prove it.
The hedge fund community appears to be salivating over Alibaba, with interest from Leon Cooperman, Dan Loeb and other major players.
William Ackman criticized Allergan's board of directors, urging them to "wake up" and at least listen to potential purchaser Valeant Pharmaceuticals.
Junk bonds have fallen about 3 percent since their peak, and some traders expect the broader stock market to follow suit—perhaps imminently.
The S&P 500 may have rallied 6 percent during the first half of the year, but the average hedge fund appears to have trailed that substantially.
While these may not be the best of times for hedge funds, they're still pretty good for the best of the best.
Early optimism about the economy may have been "misplaced," Dan Loeb's Third Point warns.
Virtually every Pershing Square Capital investment appears to have made money this year.
Happy Wednesday. We now return to our regularly scheduled program of spring.
Activist investor Dan Loeb said Sotheby's stock slide is the result of what he called "failed leadership by the board of directors."
Activist investor Daniel Loeb's Third Point has filed suit over auction house Sotheby's poison pill.
The rise and success of activist investors is changing the dynamic in the battle for corporate control, NYT reports.
Daniel Loeb's hedge fund will be losing Rhode Island as a client after the state's pension fund found his Third Point too risky.